Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Stimulation | 15 | 2024 | 29 | 6.710 |
Why?
|
| Diabetic Neuropathies | 5 | 2023 | 55 | 4.250 |
Why?
|
| Chronic Pain | 11 | 2024 | 151 | 2.750 |
Why?
|
| Diabetes Mellitus | 4 | 2023 | 309 | 2.730 |
Why?
|
| Pain Management | 12 | 2024 | 155 | 1.870 |
Why?
|
| Electric Stimulation Therapy | 5 | 2023 | 26 | 1.410 |
Why?
|
| Deep Brain Stimulation | 7 | 2020 | 49 | 1.200 |
Why?
|
| Pain Measurement | 3 | 2024 | 248 | 0.980 |
Why?
|
| Neurosurgical Procedures | 7 | 2022 | 121 | 0.960 |
Why?
|
| Complex Regional Pain Syndromes | 2 | 2020 | 9 | 0.950 |
Why?
|
| Disabled Persons | 1 | 2023 | 105 | 0.820 |
Why?
|
| Neuralgia | 3 | 2024 | 58 | 0.810 |
Why?
|
| Faculty | 1 | 2020 | 84 | 0.730 |
Why?
|
| Anesthesiology | 1 | 2020 | 46 | 0.730 |
Why?
|
| Education, Distance | 1 | 2020 | 39 | 0.730 |
Why?
|
| Stereotaxic Techniques | 4 | 2022 | 36 | 0.710 |
Why?
|
| Treatment Outcome | 13 | 2024 | 5609 | 0.630 |
Why?
|
| Subthalamic Nucleus | 3 | 2011 | 13 | 0.580 |
Why?
|
| Pandemics | 2 | 2020 | 593 | 0.550 |
Why?
|
| Humans | 37 | 2024 | 54304 | 0.530 |
Why?
|
| Peripheral Nerves | 1 | 2014 | 51 | 0.490 |
Why?
|
| Parkinson Disease | 3 | 2011 | 180 | 0.470 |
Why?
|
| Pedunculopontine Tegmental Nucleus | 1 | 2014 | 58 | 0.460 |
Why?
|
| Balamuthia mandrillaris | 1 | 2012 | 2 | 0.440 |
Why?
|
| Amebiasis | 1 | 2012 | 6 | 0.440 |
Why?
|
| Granuloma | 1 | 2012 | 45 | 0.420 |
Why?
|
| Encephalitis | 1 | 2012 | 48 | 0.420 |
Why?
|
| Pain | 3 | 2023 | 404 | 0.420 |
Why?
|
| Ganglia, Spinal | 3 | 2020 | 51 | 0.400 |
Why?
|
| Quality of Life | 5 | 2024 | 922 | 0.390 |
Why?
|
| Failed Back Surgery Syndrome | 2 | 2021 | 2 | 0.360 |
Why?
|
| Prospective Studies | 4 | 2023 | 2604 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2022 | 1616 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 487 | 0.280 |
Why?
|
| Spinal Cord | 5 | 2024 | 153 | 0.270 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 2389 | 0.260 |
Why?
|
| Middle Aged | 9 | 2021 | 13076 | 0.250 |
Why?
|
| Pain, Intractable | 1 | 2024 | 6 | 0.250 |
Why?
|
| Injections, Spinal | 2 | 2020 | 19 | 0.220 |
Why?
|
| Aged | 5 | 2023 | 10054 | 0.220 |
Why?
|
| Health Care Costs | 1 | 2023 | 176 | 0.210 |
Why?
|
| Back Pain | 2 | 2023 | 44 | 0.210 |
Why?
|
| Medicare | 1 | 2023 | 245 | 0.200 |
Why?
|
| Adult | 7 | 2020 | 14189 | 0.200 |
Why?
|
| Female | 10 | 2021 | 28457 | 0.200 |
Why?
|
| Evidence-Based Medicine | 3 | 2017 | 275 | 0.190 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2021 | 18 | 0.190 |
Why?
|
| Health Occupations | 1 | 2020 | 11 | 0.190 |
Why?
|
| Industry | 1 | 2020 | 19 | 0.190 |
Why?
|
| Sex Factors | 2 | 2020 | 766 | 0.190 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 151 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 580 | 0.190 |
Why?
|
| Neurosurgery | 2 | 2018 | 34 | 0.190 |
Why?
|
| Male | 9 | 2024 | 27335 | 0.190 |
Why?
|
| Critical Pathways | 1 | 2020 | 36 | 0.190 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 330 | 0.180 |
Why?
|
| Physicians, Women | 1 | 2020 | 23 | 0.180 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 118 | 0.180 |
Why?
|
| Physicians | 1 | 2023 | 244 | 0.180 |
Why?
|
| Electrodes, Implanted | 4 | 2014 | 29 | 0.170 |
Why?
|
| Neurology | 1 | 2020 | 46 | 0.170 |
Why?
|
| Societies, Medical | 1 | 2020 | 197 | 0.170 |
Why?
|
| Off-Label Use | 1 | 2019 | 27 | 0.170 |
Why?
|
| Physician's Role | 1 | 2019 | 51 | 0.170 |
Why?
|
| Social Media | 1 | 2020 | 104 | 0.170 |
Why?
|
| Career Choice | 1 | 2019 | 114 | 0.160 |
Why?
|
| Headache | 2 | 2015 | 78 | 0.160 |
Why?
|
| Faculty, Medical | 1 | 2019 | 100 | 0.160 |
Why?
|
| Internet | 1 | 2020 | 275 | 0.160 |
Why?
|
| General Surgery | 1 | 2019 | 113 | 0.150 |
Why?
|
| Movement Disorders | 2 | 2014 | 19 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 184 | 0.150 |
Why?
|
| Students, Medical | 1 | 2019 | 178 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 192 | 0.140 |
Why?
|
| Evoked Potentials | 2 | 2022 | 69 | 0.140 |
Why?
|
| United States | 3 | 2023 | 5204 | 0.140 |
Why?
|
| Spinal Nerves | 1 | 2015 | 11 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1693 | 0.130 |
Why?
|
| Implantable Neurostimulators | 1 | 2014 | 1 | 0.130 |
Why?
|
| Headache Disorders | 1 | 2014 | 3 | 0.130 |
Why?
|
| Migraine Disorders | 1 | 2014 | 49 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2019 | 502 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2018 | 443 | 0.110 |
Why?
|
| Steroids | 1 | 2012 | 55 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2012 | 76 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2012 | 225 | 0.100 |
Why?
|
| Parietal Bone | 1 | 2011 | 2 | 0.100 |
Why?
|
| Neuronavigation | 1 | 2010 | 11 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 531 | 0.100 |
Why?
|
| Pneumocephalus | 1 | 2010 | 6 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2010 | 53 | 0.090 |
Why?
|
| Biopsy | 1 | 2012 | 693 | 0.090 |
Why?
|
| Anesthesia | 1 | 2010 | 79 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1090 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2010 | 634 | 0.080 |
Why?
|
| Adolescent | 1 | 2020 | 6896 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 1294 | 0.080 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2020 | 11 | 0.080 |
Why?
|
| Child | 1 | 2020 | 7372 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1222 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 825 | 0.070 |
Why?
|
| Analgesics | 2 | 2019 | 107 | 0.070 |
Why?
|
| Demography | 1 | 2024 | 103 | 0.060 |
Why?
|
| Action Potentials | 1 | 2022 | 131 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 1391 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2024 | 742 | 0.050 |
Why?
|
| Patch Tests | 1 | 2021 | 9 | 0.050 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 65 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2022 | 172 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 62 | 0.050 |
Why?
|
| Erythema | 1 | 2021 | 49 | 0.050 |
Why?
|
| Young Adult | 1 | 2010 | 4313 | 0.050 |
Why?
|
| Spine | 1 | 2021 | 112 | 0.050 |
Why?
|
| Device Removal | 1 | 2021 | 97 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2020 | 145 | 0.050 |
Why?
|
| Curriculum | 1 | 2023 | 432 | 0.040 |
Why?
|
| Patient Safety | 1 | 2020 | 121 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 97 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 500 | 0.040 |
Why?
|
| Animals | 1 | 2014 | 14402 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2010 | 6462 | 0.040 |
Why?
|
| Health Status | 1 | 2020 | 368 | 0.040 |
Why?
|
| Risk Factors | 2 | 2020 | 3934 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 1361 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 453 | 0.030 |
Why?
|
| Facial Pain | 1 | 2014 | 14 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 81 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 146 | 0.030 |
Why?
|
| Patient Selection | 1 | 2014 | 284 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2014 | 270 | 0.020 |
Why?
|
| Beta Rhythm | 1 | 2010 | 5 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2010 | 20 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2010 | 94 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2010 | 51 | 0.020 |
Why?
|
| Software | 1 | 2010 | 297 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1035 | 0.010 |
Why?
|